News - Page 16 of 35 - ELANA BG Trader

Fitch upgrades Fibank to B from B- with a stable outlook

10 July 2017

Fitch upgrades Fibank or First Investment Bank (5F4 BU) to B from B- with a stable outlook. It also affirms Unicredit Bulbank and Raiffeisen Bulgaria’s BBB- with a stable outlook and United Bulgarian Bank’s BBB- with a positive outlook, according to an announcement by the rating agency. Fibank improvement Fitch’s upgrade for Fibank is driven… Read more

2.6% annual dividend yield for Speedy shareholders

6 July 2017

Speedy held regulatory shareholders’ meeting on Friday June 23rd, 2017. Shareholders approved BGN 1.13 dividend per share, yielding 2.6% at current market quotes and an ex-div day of July 5th, 2017. Speedy is increasing capital for an employee plan Speedy shareholders also approved a change in the incorporating documents of the Company to reflect the… Read more

ELANA Agrocredit will distribute BGN 0.07791 gross DPS

3 July 2017

ELANA Agrocredit shareholders voted on Annual General Meeting on 30 June 2017 to distribute BGN 1 472 751.69 of 2016 profit as dividends. 10% of the profit will be held as a reserve. ELANA Agrocredit dividend 2017 The gross dividend per share amounts at BGN 0.07791, which accounts for 5% yield according to market prices.… Read more

Sopharma Trading to acquire Serbian pharma distributor

28 June 2017

Biggest pharma distributor in Bulgaria Sopharma Trading (SO5 BU) to acquire Serbian pharma distributor Lekovit, according to a filing by the former. The acquisition is subject to an antitrust approval. Pharma stores acquisitions on the agenda The deal is part of Sopharma Trading’s plans to expand in Serbia and gain market share. The Company began… Read more

Monbat acquires two lithium-ion batteries producers in Germany

27 June 2017

Leading lead acid batteries producer in Bulgaria Monbat (5MB BU) acquired two lithium-ion batteries companies in Germany, according to a regulatory announcement by the Company. Lithium-ion batteries – the new market for Monbat Monbat acquired 100% of GAIA Akkumulatorenwerke GmbH and EAS Germany GmbH (a JV between GAIA and Enersys/Hawker). It plans to merge them… Read more

SEC approves merger on Sopharma’s Tabex US right holder

16 June 2017

US Securities and Exchange Commission approved of Sopharma’s (3JR BU) Tabex US rights holder merger, according to an announcement by Sopharma. The SEC approved the merger between Achieve Live Science and OncoGenex Pharmaceuticals with the latter expected to be approved by OncoGenex’ shareholders on Aug 1st 2017. Tabex walk to US In 2015 Sopharma sold… Read more

Media group Investor.bg plans BGN 20m capital raise, buys finance university

13 June 2017

Media Company Investor.bg (4IN BU) plans BGN 20m capital raise, according to the agenda of the upcoming extraordinary shareholders’ meeting scheduled for July 10th 2017. The Company plans to issue 1.594 million new shares with an issue price of BGN 12.95 per share and a nominal price of BGN 1 per share. Thus it will… Read more

CEO Ognyan Donev ups his stake in Sopharma

9 June 2017

CEO Ognyan Donev controlled key shareholder in Sopharma (3JR BU) ups his stake in the company, according to a regulatory filing. Donev Investments Holding has acquired 503 000 shares or 0.37% of the share capital, according to the filing. Post the transaction Donev Investments Holding’s stake has increased to 25.15%. Sopharma’s key holding structure acquires… Read more

CEZ shortlists candidates for Bulgarian assets

19 May 2017

CEZ starts negotiations with selected bidders for its Bulgarian assets – CEZ Distribution and CEZ Electro (3CZ BU and 1CZ BU), according to a statement by the Company. No details are available officially on the number of bidder or who they are. According to local media CEZ is negotiating with 4 out of 8 initial… Read more

New research report: Monbat exploring new horizons on record results

9 May 2017

Monbat, the largest lead-acid battery producer in Bulgaria, booked the best year in history in FY2016, comment ELANA Trading analysts in their FY2016 research report on the company. Sales added 8% y/y to BGN 266.5m and net profit surged 20.3% y/y to BGN 26.5m. EBITDA expanded 18.3% y/y to BGN 44.3m. Excellent performance was due… Read more